Harm Reduction
Washout Period
What is a washout period?
A washout period is the duration of time needed for a drug or substance to be eliminated from the body — typically defined as 5 half-lives of the substance in question, by which point approximately 97% has been cleared. In clinical research, washout periods are used between different treatment phases to ensure no carryover effects.
The concept applies broadly:
- Between medications: Switching from one psychiatric medication to another
- Before microdosing: Clearing existing substances that might interact
- In research: Ensuring clean baselines between experimental conditions
Why it matters for microdosing
If you are transitioning from psychiatric medication (particularly SSRIs, SNRIs, or MAOIs) to a microdosing protocol, the washout period is critical. Without adequate clearance:
- Reduced efficacy — SSRIs occupy serotonin receptors and can significantly blunt psychedelic effects
- Safety risks — combining MAOIs with psychedelics can be dangerous
- Confounded self-assessment — withdrawal effects from medication can be mistaken for microdosing effects
Typical washout periods for common medications:
| Medication | Approximate Washout |
|---|---|
| Fluoxetine (Prozac) | 4–6 weeks (long half-life) |
| Sertraline (Zoloft) | 1–2 weeks |
| Escitalopram (Lexapro) | 1–2 weeks |
| Venlafaxine (Effexor) | 1 week (taper required) |
| MAOIs | 2–3 weeks |
How it works in practice
- Never discontinue medication abruptly — always taper under medical supervision
- Calculate the washout — based on the specific medication's half-life
- Monitor withdrawal symptoms — these can be significant and should be managed
- Establish a new baseline — journal your state for at least a week after washout before beginning microdosing
- Have medical support — ideally a practitioner who understands both conventional and psychedelic approaches
What to watch out for
- Discontinuation syndrome — stopping SSRIs can cause brain zaps, dizziness, mood swings — these are NOT reasons to rush into microdosing
- Impatience — the desire to start microdosing is understandable, but cutting the washout short compromises safety and data quality
- Fluoxetine exception — its exceptionally long half-life means a longer washout than other SSRIs